China Isotope & Radiation Corp. (HK:1763) has released an update.
China Isotope & Radiation Corporation has proposed a revision of the annual caps for its continuing connected transactions, which are integral to the company’s business operations with its controlling shareholder, CNNC. The transactions under review are subject to shareholder approval and will adhere to the reporting and review requirements set by the Listing Rules. An extraordinary general meeting will be convened to seek shareholder approval for the revised annual caps, with CNNC abstaining from voting due to its substantial interest.
For further insights into HK:1763 stock, check out TipRanks’ Stock Analysis page.
